Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2482
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Diagnostic utility of BRAF V600E mutation testing in thyroid nodules in elderly patients ; volume:13 ; number:2 ; day:8 ; month:10 ; year:2013 ; pages:1-5 ; date:10.2013
BMC surgery ; 13, Heft 2 (8.10.2013), 1-5, 10.2013
- Urheber
-
Guerra, Anna
- Beteiligte Personen und Organisationen
-
Di Crescenzo, Vincenzo
Garzi, Alfredo
Cinelli, Mariapia
Carlomagno, Chiara
Pepe, Stefano
Zeppa, Pio
Tonacchera, Massimo
Vitale, Mario
SpringerLink (Online service)
- DOI
-
10.1186/1471-2482-13-S2-S37
- URN
-
urn:nbn:de:1111-2016072927516
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guerra, Anna
- Di Crescenzo, Vincenzo
- Garzi, Alfredo
- Cinelli, Mariapia
- Carlomagno, Chiara
- Pepe, Stefano
- Zeppa, Pio
- Tonacchera, Massimo
- Vitale, Mario
- SpringerLink (Online service)
Ähnliche Objekte (12)
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
BRAF V600E genetic testing should be recommended for Bethesda III or V thyroid nodules based on fine-needle aspiration
Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAF V600E/Mt to Vemurafenib
Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population
BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
Silencing FOXP2 reverses vemurafenib resistance in BRAF V600E mutant papillary thyroid cancer and melanoma cells